News & Media

News & Media2020-11-17T08:39:01+09:30

Carina Biotech appoints Cell Therapies to undertake manufacture of LGR5 CAR-T cells for clinical trial

May 31st, 2022|

Carina Biotech is pleased to announce that it has appointed Australian organisation Cell Therapies to undertake Good Manufacturing Processes (GMP)

Carina Biotech to showcase its LGR5 CAR-T program at the American Association for Cancer Research (AACR) Annual Meeting

April 6th, 2022|

Carina has had five abstracts accepted for poster presentations at the AACR Annual Meeting which will take place from April

Carina Biotech submits LGR5 CAR-T pre-IND (Investigational New Drug) package to the US Food & Drug Administration

April 1st, 2022|

Carina Biotech is very pleased to announce that we have submitted a pre-IND (Investigational New Drug) application to the US FDA (Food

Carina Biotech licenses German technology to create highly efficient CAR-T cells targeting hard-to-treat cancers

December 15th, 2021|

Carina Biotech has entered a license agreement with Bayerische Patentallianz (BayPAT) to the CXCR6-transduced CAR-T cell technology developed at the

DO YOU HAVE NEWS?

If you have a news item related to this field of medical & scientific research that you feel would be of interest to us, please contact us.